Acute induction of gene expression in brain and liver by insulin-induced hypoglycemia

Diabetes

Volumn 54, Issue 4, 2005, Pages 952-958

  Mastaitis, Jason W ^a   Wurmbach, Elisa ^a   Cheng, Hui ^a   Sealfon, Stuart C ^a   Mobbs, Charles V ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSINOGEN; GLUCOSE TRANSPORTER 1; I KAPPA B; INHIBITOR OF DIFFERENTIATION 1; INHIBITOR OF DIFFERENTIATION 2; INSULIN; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 1; PROTEIN UBP41; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN TISSUE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE MARKER; DNA MICROARRAY; GENE EXPRESSION REGULATION; GENE INDUCTION; GLUCOSE BLOOD LEVEL; HYPOGLYCEMIA; HYPOTHALAMUS; INSULIN INFUSION; LIVER; MALE; MOLECULAR MECHANICS; MOLECULAR MODEL; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM;

ANIMALS; BRAIN; DOWN-REGULATION; GENE EXPRESSION REGULATION; HYPOGLYCEMIA; INSULIN; LIVER; MALE; MICE; MICE, INBRED C57BL; MICROARRAY ANALYSIS; UP-REGULATION;

EID: 15944383378     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.54.4.952     Document Type: Article

References (37)

1. Cryer PE: Hypoglycemia begets hypoglycemia in IDDM. Diabetes 42:1691-1693, 1993
2. Sokoloff L: The brain as a chemical machine. Prog Brain Res 94:19-33, 1992
3. Borg MA, Borg WP, Tamborlane WV, Brines ML, Shulman GI, Sherwin RS: Chronic hypoglycemia and diabetes impair counterregulation induced by localized 2-deoxy-glucose perfusion of the ventromedial hypothalamus in rats. Diabetes 48:584-587, 1999
4. Borg WP, During MJ, Sherwin RS, Borg MA, Brines ML, Shulman GI: Ventromedial hypothalamic lesions in rats suppress counterregulatory responses to hypoglycemia. J Clin Invest 93:1677-1682, 1994
5. Borg WP, Sherwin RS, During MJ, Borg MA, Shulman GI: Local ventromedial hypothalamus glucopenia triggers counterregulatory hormone release. Diabetes 44:180-184, 1995
6. Borg MA, Sherwin RS, Borg WP, Tamborlane WV, Shulman GI: Local ventromedial hypothalamus glucose perfusion blocks counterregulation during systemic hypoglycemia in awake rats. J Clin Invest 99:361-365, 1997
7. Cranston I, Reed LJ, Marsden PK, Amiel SA: Changes in regional brain (18)F-fluorodeoxyglucose uptake at hypoglycemia in type 1 diabetic men associated with hypoglycemia unawareness and counter-regulatory failure. Diabetes 50:2329-2336, 2001
8. Mitrakou A, Mokan M, Ryan C, Veneman T, Cryer P, Gerich J: Influence of plasma glucose rate of decrease on hierarchy of responses to hypoglycemia. J Clin Endocrinol Metab 76:462-465, 1993
9. Segel SA, Fanelli CG, Dence CS, Markham J, Videen TO, Paramore DS, Powers WJ, Cryer PE: Blood-to-brain glucose transport, cerebral glucose metabolism, and cerebral blood flow are not increased after hypoglycemia. Diabetes 50:1911-1917, 2001
10. Horinaka N, Kuang TY, Pak H, Wang R, Jehle J, Kennedy C, Sokoloff L: Blockade of cerebral blood flow response to insulin-induced hypoglycemia by caffeine and glibenclamide in conscious rats. J Cereb Blood Flow Metab 17:1309-1318, 1997
11. Tang Y, Lu A, Aronow BJ, Wagner KR, Sharp FR: Genomic responses of the brain to ischemic stroke, intracerebral haemorrhage, kainate seizures, hypoglycemia, and hypoxia. Eur J Neurosci 15:1937-1952, 2002
12. Wurmbach E, Yuen T, Ebersole BJ, Sealfon SC: Gonadotropin-releasing hormone receptor-coupled gene network organization. J Biol Chem 276:47195-47201, 2001
13. Wurmbach E, Gonzalez-Maeso J, Yuen T, Ebersole BJ, Mastaitis JW, Mobbs CV, Sealfon SC: Validated genomic approach to study differentially expressed genes in complex tissues. Neurochem Res 27:1027-1033, 2002
14. Yuen T, Zhang W, Ebersole BJ, Sealfon SC: Monitoring G-protein-coupled receptor signaling with DNA microarrays and real-time polymerase chain reaction. Methods Enzymol 345:556-569, 2002
15. Shu IW, Lindenberg DL, Mizuno TM, Roberts JL, Mobbs CV: The fatty acid synthase inhibitor cerulenin and feeding, like leptin, activate hypothalamic pro-opiomelanocortin (POMC) neurons. Brain Res 985:1-12, 2003
16. Buchanan TA, Thawani H, Kades W, Modrall JG, Weaver FA, Laurel C, Poppiti R, Xiang A, Hsueh W: Angiotensin II increases glucose utilization during acute hyperinsulinemia via a hemodynamic mechanism. J Clin Invest 92:720-726, 1993
17. Tang W, Richards EM, Raizada MK, Sumners C: Angiotensin II increases glucose uptake and glucose transporter-1 mRNA levels in astroglia. Am J Physiol 268:E384-E390, 1995
18. Duff JL, Monia BP, Berk BC: Mitogen-activated protein (MAP) kinase is regulated by the MAP kinase phosphatase (MKP-1) in vascular smooth muscle cells: effect of actinomycin D and antisense oligonucleotides. J Biol Chem 270:7161-7166, 1995
19. Kusari AB, Byon J, Bandyopadhyay D, Kenner KA, Kusari J: Insulin-induced mitogen-activated protein (MAP) kinase phosphatase-1 (MKP-1) attenuates insulin-stimulated MAP kinase activity: a mechanism for the feedback inhibition of insulin signaling. Mol Endocrinol 11:1532-1543, 1997
20. Takehara N, Kawabe J, Aizawa Y, Hasebe N, Kikuchi K: High glucose attenuates insulin-induced mitogen-activated protein kinase phosphatase-1 (MKP-1) expression in vascular smooth muscle cells. Biochim Biophys Acta 1497:244-252, 2000.
21. Simpson IA, Appel NM, Hokari M, Oki J, Holman GD, Maher F, Koehler-Stec EM, Vannucci SJ, Smith QR: Blood-brain barrier glucose transporter: effects of hypo- and hyperglycemia revisited. J Neurochem 72:238-247, 1999
22. Boyle PJ, Nagy RJ, O'Connor AM, Kempers SF, Yeo RA, Quails C: Adaptation in brain glucose uptake following recurrent hypoglycemia. Proc Natl Acad Sci U S A 91:9352-9356, 1994
23. Tkacs NC, Dunn-Meynell AA, Levin BE: Presumed apoptosis and reduced arcuate nucleus neuropeptide Y and pro-opiomelanocortin mRNA in non-coma hypoglycemia. Diabetes 49:820-826, 2000
24. Katada J, Muramatsu M, Hayashi I, Tsutsumi M, Konishi Y, Majima M: Significance of vascular endothelial cell growth factor up-regulation mediated via a chymase-angiotensin-dependent pathway during angiogenesis in hamster sponge granulomas. J Pharmacol Exp Ther 302:949-956, 2002
25. Shihab FS, Bennett WM, Isaac J, Yi H, Andoh TF: Angiotensin II regulation of vascular endothelial growth factor and receptors Fit-1 and KDR/Flk-1 in cyclosporine nephrotoxicity. Kidney Int 62:422-433, 2002
26. Tamarat R, Silvestre JS, Durie M, Levy BI: Angiotensin II angiogenic effect in vivo involves vascular endothelial growth factor- and inflammation-related pathways. Lab Invest 82:747-756, 2002
27. Benezra R: Role of Id proteins in embryonic and tumor angiogenesis. Trends Cardiovasc Med 11:237-241, 2001
28. Pekala P, Marlow M, Heuvelman D, Connolly D: Regulation of hexose transport in aortic endothelial cells by vascular permeability factor and tumor necrosis factor-alpha, but not by insulin. J Biol Chem 265:18051-18054, 1990
29. Dantz D, Bewersdorf J, Fruehwald-Schultes B, Kern W, Jelkmann W, Born J, Fehm HL, Peters A: Vascular endothelial growth factor: a novel endocrine defensive response to hypoglycemia. J Clin Endocrinol Metab 87:835-840, 2002
30. Paulson OB: Blood-brain barrier, brain metabolism and cerebral blood flow. Eur Neuropsychopharmacol 12:495-501, 2002
31. Knudsen GM, Pettigrew KD, Patlak CS, Paulson OB: Blood-brain barrier permeability measurements by double-indicator method using intravenous injection. Am J Physiol 266:H987-H999, 1994
32. Zeller K, Rahner-Welsch S, Kuschinsky W: Distribution of Glut1 glucose transporters in different brain structures compared to glucose utilization and capillary density of adult rat brains. J Cereb Blood Flow Metab 17:204-209, 1997
33. Kim YB, Uotani S, Pierroz DD, Flier JS, Kahn BB: In vivo administration of leptin activates signal transduction directly in insulin-sensitive tissues: overlapping but distinct pathways from insulin. Endocrinology 141:2328-2339, 2000
34. Yang XJ, Kow LM, Funabashi T, Mobbs CV: Hypothalamic glucose sensor: similarities to and differences from pancreatic β-cell mechanisms. Diabetes 48:1763-1672, 1999
35. Dunn-Meynell AA, Routh VH, Kang L, Gaspers L, Levin BE: Glucokinase is the likely mediator of glucosensing in both glucose-excited and glucose-inhibited central neurons. Diabetes 51:2056-2065, 2002
36. Yang XJ, Kow LM, Pfaff DW, Mobbs CV: Metabolic pathways that mediate inhibition of hypothalamic neurons by glucose. Diabetes 53:67-73, 2004
37. Matschinsky FM, Glaser B, Magnuson MA: Pancreatic β-cell glucokinase: closing the gap between theoretical concepts and experimental realities. Diabetes 47:307-315, 1998